SIROLIMUS DOSE-NORMALIZED TROUGHS WERE AFFECTED BY TIME POST SIROLIMUS INITIATION, CONCOMITANT TACROLIMUS THERAPY, AND MDR-1 3435C > T POLYMORPHISM IN RENAL TRANSPLANT PATIENTS WHO ARE CYP3A5 NON-EXPRESSERS
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Sam, W-J; Chamberlain, CE; Lee, S-J; Goldstein, JA; Hale, DA; Kirk, AD; Mannon, RB; Hon, YY
Published Date
- September 1, 2009
Published In
Volume / Issue
- 49 / 9
Start / End Page
- 1107 - 1107
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0091-2700
Conference Name
- 38th Annual Meeting of the American-College-of-Clinical-Pharmacology
Conference Location
- San Antonio, TX
Conference Start Date
- September 13, 2009
Conference End Date
- September 15, 2009